Arama Sonuçları - Nima Rezaei

Sonuçları Daraltın
  1. 1
    COVID-19 affects healthy pediatricians more than pediatric patients

    COVID-19 affects healthy pediatricians more than pediatric patients Yazar: Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Artificial intelligence and immunotherapy

    Artificial intelligence and immunotherapy Yazar: Parnian Jabbari, Nima Rezaei

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Editorial
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Immune-epidemiological parameters of the novel coronavirus – a perspective

    Immune-epidemiological parameters of the novel coronavirus – a perspective Yazar: Amene Saghazadeh, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Case Report: Death due to COVID-19 in Three Brothers

    Case Report: Death due to COVID-19 in Three Brothers Yazar: Sedigheh Yousefzadegan, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Genetic predisposition models to COVID-19 infection

    Genetic predisposition models to COVID-19 infection Yazar: Farzaneh Darbeheshti, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids

    Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids Yazar: Amene Saghazadeh, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Central Nervous System Involvement in COVID-19

    Central Nervous System Involvement in COVID-19 Yazar: Leila Jahanshahlu, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences

    SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences Yazar: Melika Lotfi, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Lymphopenia in COVID‐19: Therapeutic opportunities

    Lymphopenia in COVID‐19: Therapeutic opportunities Yazar: Nazanin Fathi, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Monoclonal antibody as a potential anti-COVID-19

    Monoclonal antibody as a potential anti-COVID-19 Yazar: Leila Jahanshahlu, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  11. 11
    With Risk of Reinfection, Is COVID-19 Here to Stay?

    With Risk of Reinfection, Is COVID-19 Here to Stay? Yazar: Parnian Jabbari, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?

    Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor? Yazar: Fateme Babaha, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Immunotherapy for SARS-CoV-2: potential opportunities

    Immunotherapy for SARS-CoV-2: potential opportunities Yazar: Mehrnoosh Pashaei, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  14. 14
    COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment

    COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment Yazar: Shaghayegh Sadeghmousavi, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  15. 15
    CRISPR/Cas13: A potential therapeutic option of COVID-19

    CRISPR/Cas13: A potential therapeutic option of COVID-19 Yazar: Melika Lotfi, Nima Rezaei

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Role of Toll‐like receptors in the pathogenesis of COVID‐19

    Role of Toll‐like receptors in the pathogenesis of COVID‐19 Yazar: Shaghayegh Khanmohammadi, Nima Rezaei

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review

    Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review Yazar: Sara Momtazmanesh, Nima Rezaei

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Autoimmune complications of COVID‐19

    Autoimmune complications of COVID‐19 Yazar: Niloufar Yazdanpanah, Nima Rezaei

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Poxviruses and the immune system: Implications for monkeypox virus

    Poxviruses and the immune system: Implications for monkeypox virus Yazar: Amene Saghazadeh, Nima Rezaei

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Insights on Mpox virus infection immunopathogenesis

    Insights on Mpox virus infection immunopathogenesis Yazar: Amene Saghazadeh, Nima Rezaei

    Baskı/Yayın Bilgisi 2023
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: